Healthcare focused private equity firm DW Healthcare Partners has sold of one of its portfolio companies, Tandem Labs, to Laboratory Corporation of America Holdings or LabCorp.
Subscribe to our email newsletter
Tandem Labs is a bioanalytical and immunoanalytical contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs.
The sale of Tandem Labs generated approximately a return of 6.9 times the invested capital for DW Healthcare’s investors.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.